1: \begin{abstract}

2: Suppose we are interested in the effect of a treatment in a clinical trial. The efficiency of inference may be limited due to small sample size. However, external control data are often

3: available from  historical   studies. Motivated by an application to Helicobacter pylori infection, we show how to borrow strength from such data to improve efficiency of inference  in the clinical trial.  Under an exchangeability assumption about the potential outcome mean, we show that the semiparametric efficiency bound for estimating the 

4: average treatment effect can be reduced by   incorporating  both  the clinical trial data and  external controls.  

5: We then derive a doubly robust and locally  efficient estimator.  The improvement in efficiency  is prominent especially when the external control dataset has a large sample size and  small variability. 

6: Our method  allows for a relaxed overlap assumption, and we illustrate with the case where the clinical trial only  contains a treated group.   We also develop  doubly robust and locally efficient approaches that extrapolate the causal effect in the clinical trial to the external  population and the overall population. Our results also offer a meaningful implication for trial design and data collection.

7: We evaluate the finite-sample performance of the proposed estimators via simulation. 

8: In the Helicobacter pylori infection application, our approach shows  that the combination treatment has potential efficacy advantages over the triple therapy.

9: 	\bigskip

10: 	

11: 	\noindent\emph{Key words}: Data combination; Double robustness; Efficiency; External control.

12: \end{abstract}

13: